Holen Sie sich die Stockscreener-App
15.84
1.02%
0.16
Handel nachbörslich:
15.88
0.04
+0.25%
Schlusskurs vom Vortag:
$15.68
Offen:
$15.57
24-Stunden-Volumen:
157.03K
Relative Volume:
0.72
Marktkapitalisierung:
$844.23M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-83.74M
KGV:
-9.8385
EPS:
-1.61
Netto-Cashflow:
$-64.98M
1W Leistung:
+11.31%
1M Leistung:
+13.22%
6M Leistung:
+53.79%
1J Leistung:
-5.04%
1-Tages-Spanne:
$15.13
$16.05
1-Wochen-Bereich:
$14.21
$16.05
52-Wochen-Spanne:
$6.42
$17.78
Tyra Biosciences Inc Stock (TYRA) Company Profile
Firmenname
Tyra Biosciences Inc
Sektor
Branche
Telefon
(619) 728-4760
Adresse
2656 STATE STREET, CARLSBAD
Vergleichen Sie TYRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TYRA
Tyra Biosciences Inc
|
15.84 | 835.70M | 0 | -83.74M | -64.98M | -1.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-03 | Eingeleitet | Raymond James | Strong Buy |
| 2025-05-21 | Fortgesetzt | Piper Sandler | Overweight |
| 2025-01-07 | Eingeleitet | UBS | Buy |
| 2024-10-18 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-08-15 | Eingeleitet | Piper Sandler | Overweight |
| 2023-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-06-30 | Eingeleitet | Wedbush | Outperform |
| 2023-02-03 | Eingeleitet | Oppenheimer | Outperform |
| 2022-06-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-03-08 | Hochstufung | Jefferies | Hold → Buy |
| 2021-11-08 | Herabstufung | Jefferies | Buy → Hold |
| 2021-10-11 | Eingeleitet | BofA Securities | Buy |
| 2021-10-11 | Eingeleitet | Cowen | Outperform |
| 2021-10-11 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Tyra Biosciences Inc Aktie (TYRA) Neueste Nachrichten
Tyra Biosciences, Inc. (NASDAQ:TYRA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Risk vs reward if holding onto Tyra Biosciences Inc.2025 Biggest Moves & Step-by-Step Swing Trade Plans - newser.com
How Tyra Biosciences Inc. stock performs during Fed tightening cyclesOil Prices & Weekly Watchlist for Consistent Profits - newser.com
Heatmap analysis for Tyra Biosciences Inc. and competitorsWeekly Volume Report & Fast Entry and Exit Trade Plans - newser.com
Historical volatility pattern of Tyra Biosciences Inc. visualizedJuly 2025 PostEarnings & Real-Time Chart Breakout Alerts - newser.com
Is Tyra Biosciences Inc. stock poised for growthQuarterly Earnings Summary & Long-Term Capital Growth Ideas - newser.com
Tyra Biosciences (TYRA) Projected to Post Earnings on Thursday - MarketBeat
Signal strength of Tyra Biosciences Inc. stock in tech scanners2025 Performance Recap & High Conviction Investment Ideas - newser.com
Will Tyra Biosciences Inc. continue its uptrendJuly 2025 Closing Moves & Free Low Drawdown Momentum Trade Ideas - newser.com
Does Tyra Biosciences Inc. fit your quant trading modelJuly 2025 Decliners & Fast Exit Strategy with Risk Control - newser.com
AlphaQuest LLC Has $699,000 Stock Holdings in Tyra Biosciences, Inc. $TYRA - MarketBeat
What’s the recovery path for long term holders of Tyra Biosciences Inc.Quarterly Investment Review & Capital Protection Trade Alerts - newser.com
Tyra Biosciences backs cancer forum to advance urologic oncology - Traders Union
Finanzdaten der Tyra Biosciences Inc-Aktie (TYRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.62%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):